Director/PDMR Shareholding
Optima Health plc announced on 28 September 2026 that on 23 September 2026, nil-cost options were granted under the Performance Share Plan to directors and PDMRs, including CEO Jonathan Thomas, CFO Andy Bones, and CCO Joanne Newey. These options vest in two years, subject to continued employment and performance targets, with 50% of vested shares subject to an additional one-year holding period. A total of 560,974 ordinary shares were granted as nil-cost options to these individuals, with Jonathan Thomas receiving 284,552 options and Joanne Newey receiving 113,821 options. Additionally, awards under the 2024 share plan have been granted to senior management/PDMRs, also as nil-cost options contingent on performance hurdles.
Select text to share a quote on X · sign in to keep highlights & notes in your OPT notes
Optima Health plc (Company) announces that on 23 September 2026, awards were granted under the Optima Health plc Performance Share Plan (PSP) to certain directors and PDMRs.
The Awards take the form of nil-cost options which vest on the second anniversary of grant, subject to certain conditions including continued employment with the group and the achievement of performance targets. 50% of the shares that vest are then subject to a further one year holding period before they can be exercised.
In addition, further to the information on the 2024 Share Plan set out in the Company’s Admission Document and the recent notice of Annual General Meeting, the Company confirms that awards under the 2024 share plan have been granted to a number of senior management/PDMRs. Subject to achievement of the performance hurdle, nil cost options would be granted to the relevant participants according to the plan rules.
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation as incorporated into the law of England and Wales, and set out more details of the transactions.
| 1. | Details of PDMR | |
| (a) | Name | 1. Jonathan Thomas 2. Andy Bones 3. Joanne Newey |
| 2. | Reason for notification | |
| (b) | Position / status | 1. Chief Executive Officer 2. Chief Financial Officer 3. Chief Commercial Officer (PDMR) |
| (c) | Initial notification / amendment | Initial notification |
| 3. | Details of the Issuer | |
| (a) | Name | Optima Health plc |
| (b) | LEI | 213800TOPWJSRCW4ON08 |
| (a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares in the capital of Optima Health plc ( Shares ) GB00BRSCY602 |
| (b) | Nature of the transaction | Grant of an option under the PSP to acquire Shares at nil cost |
| (c) | Price(s) and volume | Price(s) Volume Nil 1. 284,552 2. 162,601 3. 113,821 |
| (d) | Aggregated information | Volume Price 560,974 Nil |
| (e) | Date of the transaction | 23 September 2026 |
| (f) | Place of the transaction | Outside a trading venue |
| Name of PDMR | Cumulative % of total value of 2024 Share Plan value (subject to performance hurdles) | |
| Jonathan Thomas | 50% | |
| Joanne Newey | 10% |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.